28-Mar-2024
Benzinga (Thu, 28-Mar 2:08 PM ET)
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
Benzinga (Tue, 26-Mar 10:36 AM ET)
Summit Therapeutics’ Ivonescimab: A Potential New Standard in Oncology Market Challenging Keytruda
TipRanks (Mon, 25-Mar 4:25 PM ET)
Business Wire (Fri, 22-Mar 7:00 AM ET)
Business Wire (Thu, 14-Mar 7:00 AM ET)
PRNewswire (Mon, 11-Mar 6:05 PM ET)
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
Business Wire (Tue, 5-Mar 7:00 AM ET)
Business Wire (Mon, 26-Feb 4:00 AM ET)
Business Wire (Tue, 20-Feb 7:00 AM ET)
Summit Therapeutics to Host Fourth Quarter & Full Year 2023
Business Wire (Wed, 14-Feb 7:00 AM ET)
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Summit Therapeutics trades on the NASDAQ stock market under the symbol SMMT.
As of March 28, 2024, SMMT stock price climbed to $4.14 with 4,529,500 million shares trading.
SMMT has a beta of 0.10, meaning it tends to be less sensitive to market movements. SMMT has a correlation of 0.00 to the broad based SPY ETF.
SMMT has a market cap of $2.91 billion. This is considered a Mid Cap stock.
In the last 3 years, SMMT stock traded as high as $8.70 and as low as $.66.
The top ETF exchange traded funds that SMMT belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.
SMMT has outperformed the market in the last year with a return of +140.7%, while the SPY ETF gained +33.6%. In the last 3 month period, SMMT beat the market returning +50.0%, while SPY returned +10.1%. However, in the most recent 2 weeks SMMT has underperformed the stock market by returning -8.2%, while SPY returned +1.7%.
SMMT support price is $3.49 and resistance is $4.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SMMT stock will trade within this expected range on the day.